Skip to content
Search

Latest Stories

Stephen Kinnock visits Bedminster Pharmacy, gets winter flu vaccination

Stephen Kinnock visits Bedminster Pharmacy, gets winter flu vaccination

The minister engaged with pharmacy staff to discuss the potential of community pharmacies in advancing the government’s ambitious plans for NHS renewal

Stephen Kinnock highlighted the crucial role that pharmacies will play in shifting care from hospitals into the community during his visit to the multi-award-winning Bedminster Pharmacy in Bristol on Thursday, 24 October.


It was his first visit to a community pharmacy since taking office as the minister of state department of health and social care, with responsibility for community pharmacy.

The visit allowed Kinnock to witness firsthand the array of services provided by community pharmacies, positioning them at the centre of accessible neighbourhood population health and wellbeing.

Bedminster Pharmacy team 1

He also engaged with pharmacy staff and patients to understand better the sector’s challenges and its potential to support the government’s agenda for NHS renewal, especially as a public consultation on the future of the NHS is currently underway.

While speaking with members of the Bedminster Pharmacy team, he shared about his journey into public service and the values that drive his work to make a positive difference.

He also took the opportunity to receive his annual winter flu vaccination at the pharmacy.

image2

Reflecting on the visit, Kinnock said: “I was delighted to visit Bedminster Pharmacy today and see first-hand the fantastic work they do. I heard about the challenges that pharmacies and pharmacists face and saw how integral they are to their community.’’

“We inherited a broken NHS, where pharmacies have been neglected for years. As we shift care out of the hospital and into the community, we will support community pharmacies and pharmacists who will be crucial to making a healthcare system fit for the future.”

Ade Williams, MBE, superintendent pharmacist at Bedminster Pharmacy, emphasised the significance of Kinnock’s visit, stating: “Receiving the minister today provided the opportunity to show firsthand how community pharmacy, even in the face of ongoing challenges, continues to make a difference in the lives of our patients.”

“It was good to discuss firsthand our expansive potential to help drive forward the ambitious plans for NHS renewal.”

“I am especially grateful he took the time to talk with our pharmacy team and patients. The dedication of our team and the trust patients invest in us continues to define the values and success of the NHS and our responsibility in community pharmacy as its most accessible outpost.’’

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less